Veeva Systems (NYSE:VEEV – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 7.930-7.93 for the period, compared to the consensus EPS estimate of 6.890. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.1 billion. Veeva Systems also updated its Q4 2026 guidance to 1.920-1.920 EPS.
Veeva Systems Trading Down 9.8%
Shares of NYSE:VEEV opened at $243.98 on Friday. Veeva Systems has a twelve month low of $201.54 and a twelve month high of $310.50. The company has a market cap of $39.99 billion, a PE ratio of 50.10, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The company’s 50 day moving average is $287.74 and its 200 day moving average is $278.52.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.95 by $0.09. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The business had revenue of $811.24 million for the quarter, compared to the consensus estimate of $792.37 million. During the same period in the prior year, the firm earned $1.75 EPS. The business’s revenue for the quarter was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS. Q4 2026 guidance at 1.920-1.920 EPS. Equities research analysts predict that Veeva Systems will post 4.35 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Read Our Latest Report on VEEV
Insider Buying and Selling
In related news, SVP Jonathan Faddis sold 14,595 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This trade represents a 62.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of Veeva Systems stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the sale, the insider owned 25,325 shares in the company, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. Insiders own 10.30% of the company’s stock.
Institutional Trading of Veeva Systems
Several large investors have recently made changes to their positions in the company. Sivia Capital Partners LLC boosted its position in shares of Veeva Systems by 225.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after acquiring an additional 2,164 shares during the last quarter. L2 Asset Management LLC acquired a new stake in Veeva Systems during the third quarter worth about $210,000. Brooklyn Investment Group raised its stake in Veeva Systems by 64.6% during the third quarter. Brooklyn Investment Group now owns 790 shares of the technology company’s stock worth $235,000 after purchasing an additional 310 shares during the period. Brown Brothers Harriman & Co. boosted its holdings in Veeva Systems by 8.1% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock valued at $214,000 after purchasing an additional 54 shares during the last quarter. Finally, Epoch Investment Partners Inc. acquired a new position in Veeva Systems in the 3rd quarter valued at about $225,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
- Five stocks we like better than Veeva Systems
- What is a Low P/E Ratio and What Does it Tell Investors?
- MarketBeat Week in Review – 11/17 – 11/21
- Breakout Stocks: What They Are and How to Identify Them
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- How to Short a Stock in 5 Easy Steps
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
